HitIQ Limited (AU:HIQ) has released an update.
HITIQ Limited, a pioneer in concussion management solutions, has received approval for its second US Patent for its Nexus™ technology, enhancing its intellectual property portfolio. The patent promises to streamline the production and functionality of its instrumented mouthguard devices, catering to both the premium custom and mass market sectors. This technological advancement is expected to facilitate the transition of HITIQ’s mouthguard technology from specialized research to widespread commercial use, benefiting sports participants at all levels.
For further insights into AU:HIQ stock, check out TipRanks’ Stock Analysis page.
